Protein carbonylation in human diseases

Area of Science:

• Biochemistry
• Molecular Biology
• Pathology

Background:

• Oxidative modifications of proteins are implicated in the development and progression of numerous human diseases.
• Protein carbonylation is a key indicator of severe oxidative protein damage.
• Diseases such as Alzheimer's, diabetes, and sepsis are associated with elevated protein carbonylation.

Purpose of the Study:

• To highlight the role of oxidative protein damage in human diseases.
• To emphasize protein carbonyl content as a biomarker for oxidative stress.
• To discuss the potential of identifying carbonylated proteins for diagnostics and therapy.

Main Methods:

• Review of existing literature on protein carbonylation and its association with diseases.
• Analysis of the significance of protein carbonyl content as a biomarker.
• Discussion of recent advancements in identifying carbonylated proteins.

Main Results:

• Protein carbonylation is a widespread consequence of oxidative stress in various pathologies.
• The measurement of protein carbonyl content serves as a general biomarker for oxidative protein damage.
• Advancements in identifying specific carbonylated proteins are emerging.

Conclusions:

• Identifying specific carbonylated proteins can lead to novel diagnostic biomarkers for oxidative damage, potentially enabling pre-symptomatic detection.
• This research provides foundational information for developing effective antioxidant therapies.
• Understanding protein carbonylation is crucial for both disease diagnostics and therapeutic interventions.